搜索筛选:
搜索耗时1.1101秒,为你在为你在102,267,441篇论文里面共找到 9 篇相符的论文内容
类      型:
[期刊论文] 作者:Atsushi Umemura,Rion Takahashi, 来源:电力能源(英文) 年份:2020
In recent years, power generation using renewable energy sources has been developed as a solution to the global warming problem. Among these power generation me...
[期刊论文] 作者:Rion Takahashi,Atsushi Umemura, 来源:电力能源(英文) 年份:2020
This paper proposes a power control method to improve a stability of a small-scale power grid with renewable energy sources. In an isolated small- scale power g...
[期刊论文] 作者:Linda Sartika,Atsushi Umemura,, 来源:机械工程与自动化:英文版 年份:2017
[期刊论文] 作者:Atsushi Umemura,Miwako Miyata,, 来源:帕金森(英文) 年份:2015
Background: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is widely performed for medically refractory Parkinson’s disease (PD). Several wester...
[期刊论文] 作者:Shoyu Onuka,Atsushi Umemura,Ri, 来源:电力能源(英文) 年份:2020
Recently, introduction of renewable energy sources like wind power generation and photovoltaic power generation has been increasing from the viewpoint of enviro...
[期刊论文] 作者:Hideki Fujii,Atsushi Umemura,T, 来源:世界肝病学杂志:英文版(电子版) 年份:2017
AIM To investigate daclatasvir(DCV) and asunaprevir(ASV) efficacy in hepatitis C(HCV) patients, with respect to resistance-associated substitutions(RASs).METHOD...
[期刊论文] 作者:Atsushi Umemura,Yuichi Oka,Rik, 来源:帕金森(英文) 年份:2013
Subthalamic nucleus deep brain stimulation (STN DBS) is an effective treatment for medically refractory Parkinson’s disease (PD). However, a minority of patien...
[期刊论文] 作者:Hideki Fujii,Atsushi Umemura,Taichiro Nishikawa,Kanji Yamaguchi,Michihisa Moriguchi,Hideki Nakamura,Kohichiroh, 来源:World Journal of Hepatology 年份:2017
AIM To investigate daclatasvir(DCV) and asunaprevir(ASV) efficacy in hepatitis C(HCV) patients, with respect to resistance-associated substitutions(RASs).METHOD...
[期刊论文] 作者:Hideki Fujii,Takeshi Nishimura,Atsushi Umemura,Taichiro Nishikawa,Kanji Yamaguchi,Michihisa Moriguchi, 来源:World Journal of Hepatology 年份:2015
AIM: To compare efficacy of telaprevir(TVR) and simeprevir(SMV) combined with pegylated interferon(PEG-IFN) and ribavirin(RBV) while treating chronic hepatitis...
相关搜索: